financetom
Business
financetom
/
Business
/
China's TCL Zhonghuan, JinkoSolar to set up joint ventures with Saudi sovereign fund
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's TCL Zhonghuan, JinkoSolar to set up joint ventures with Saudi sovereign fund
Jul 16, 2024 5:30 AM

BEIJING, July 16 (Reuters) - Two of China's top solar

firms have signed joint ventures with Saudi Arabia's sovereign

investment fund to set up factories in the kingdom worth

billions of dollars, they said on Tuesday.

China's TCL Zhonghuan Renewable Energy Technology

said its Singapore unit planned to set up a joint

venture with partners including a subsidiary of Saudi Arabia's

Public Investment Fund (PIF) to manufacture silicon crystal and

silicon wafers in Saudi Arabia.

TCL's LumeTech, PIF's Renewable Energy Localization Co and

Vision Industries Co will invest around a combined $2.08 billion

in the 20 gigawatt (GW) per year project, the company said in a

Shenzhen Stock Exchange filing.

Their respective stakes in the joint venture will be 40%,

40%, and 20%, it said.

Separately, JinkoSolar ( JKS ) said in a Tuesday filing that it had

signed an agreement with the same Saudi partners for a project

producing 10 GW per year of solar cells and modules in the

kingdom.

The companies' combined investment in the project is

estimated at 3.693 billion riyals ($985 million), the filing

said, with Jinko holding a 40% stake.

PIF governor Yasir Al-Rumayyan, who is also chairman of

Saudi Aramco, met last week with China's Commerce Minister Wang

Wentao.

Wang said in the meeting that China would deepen its

cooperation with the kingdom in areas including energy, trade,

and investment.

TCL said in a WeChat post that the project, TCL's first

manufacturing silicon crystal and silicon wafers overseas, would

be of great significance to China's Belt and Road infrastructure

strategy.

(Reporting by Ella Cao and Colleen Howe; Editing by Kirsten

Donovan and Emelia Sithole-Matarise)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Security Properties Closes $400.8 Million Acquisition
Security Properties Closes $400.8 Million Acquisition
Sep 17, 2025
The Sale Marks One of the Single Largest Multifamily Transaction in the Seattle Area in 2025 SEATTLE, Sept. 17, 2025 /PRNewswire/ -- Security Properties, the leading real estate investment firm in the Pacific Northwest, has completed one of the largest multifamily acquisitions in the Seattle area so far this year, purchasing a five-property, 903-unit Seattle portfolio from Washington Holdings for $400.8 million....
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
Sep 17, 2025
EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ( XOMA ) , a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of HilleVax, Inc. ( HLVX ) (“HilleVax”) common stock...
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Sep 17, 2025
HOPKINTON, Mass.--(BUSINESS WIRE)-- Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyout[1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics (“Isto”) from Thompson Street Capital Partners (“TSCP”). TSCP will retain a minority stake, alongside Isto Biologics’ management team. Founded in 2016, Isto Biologics is a regenerative MedTech company...
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
Sep 17, 2025
$800 Million Investment Powers America’s First Gigafactory for Lithium-Ion Separators, Strengthening American Supply Chains and Economic Security MIAMI--(BUSINESS WIRE)-- I Squared Capital (“I Squared”), a leading global infrastructure investment manager, today announced it has signed a definitive agreement to acquire a majority equity interest in ENTEK Technology Holdings LLC (“ENTEK”), a leading global manufacturer of battery separators. I Squared’s...
Copyright 2023-2026 - www.financetom.com All Rights Reserved